Skip to ContentSkip to Navigation
University of Groningenfounded in 1614  -  top 100 university
About us Practical matters How to find us dr. E. Meijer

Research interests

Esther Meijer is an internist-nephrologist with specific interest in Autosomal Dominant Polycystic Kidney Disease (ADPKD). At the University Medical Center Groningen (UMCG), she combines clinical work with research. She sees approximately 250 ADPKD patients per year and is study coordinator of a Dutch national observational cohort of ADPKD patients. Her current research focuses on markers of disease progression, and improving treatment in ADPKD. In 2019, she received an early career grant from the Dutch Kidney Foundation to investigate improvement of treatment with a vasopressin V2 receptor antagonist, by decreasing the adverse events. 

Publications

Caught Between Now and Next: A Qualitative Study into Final-Year Medical Students' Clerkship Choices

Clinical Spectrum and Prognosis of Atypical Autosomal Dominant Polycystic Kidney Disease Caused by Monoallelic Pathogenic Variants of IFT140

Diagnosis, management and treatment of the Alport syndrome - 2024 guideline on behalf of ERKNet, ERA and ESPN

Family Planning in Patients With ADPKD–Results From the DIPAK Consortium

In Reply to "Kidney Cysts in Alport Syndrome: Illustrative Cases, but Misleading Conclusions"

Kidney Cysts in Autosomal Dominant Polycystic Kidney Disease and Alport Syndrome: Two Familial Cases Illustrating Diagnostic Challenges

Predicting Kidney Outcomes in Autosomal Dominant Polycystic Kidney Disease: A Comprehensive Biomarker Analysis

Prospective Study on Individualized Dose Adjustment of Tolvaptan Based on Urinary Osmolality in Patients With ADPKD

The long-term effect of tolvaptan treatment on kidney function and volume in patients with ADPKD

Effects of salt and protein intake on polyuria in V2RA-treated ADPKD patients